Marc Ghany

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B

National Institute of Diabetes and Digestive and Kidney Diseases · ZIA

Contact PI · $9.6M · National Institute of Diabetes and Digestive and Kidney Diseases

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C

National Institute of Diabetes and Digestive and Kidney Diseases · ZIA

Contact PI · $7.2M · National Institute of Diabetes and Digestive and Kidney Diseases

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B

National Institute of Diabetes and Digestive and Kidney Diseases · Z01

Contact PI · $567.1K · National Institute of Diabetes and Digestive and Kidney Diseases

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C

National Institute of Diabetes and Digestive and Kidney Diseases · Z01

Contact PI · $378.1K · National Institute of Diabetes and Digestive and Kidney Diseases

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

Principal investigator · Recruiting · Phase 2

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Principal investigator · Completed

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B

Principal investigator · Withdrawn · Phase 2

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Principal investigator · Active not recruiting · Phase 4

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)